AMR Clinical

AMR Clinical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AMR Clinical is a private, services-oriented company that provides integrated clinical trial site management and patient recruitment services. With a network of 30+ sites and a database of over 1 million potential participants, the company leverages decades of collective experience to deliver fast startup, high enrollment, and quality data for sponsors, particularly in infectious diseases. Its business model is built on a centralized infrastructure that ensures consistency across sites, helping to de-risk and accelerate clinical development programs for its clients. The company is revenue-generating, with a track record of contributing to over 30 new drug approvals in the past five years.

Infectious DiseaseDiagnostics

Technology Platform

Operational platform consisting of a centralized, integrated network of 30+ clinical research sites, a proprietary database of 1M+ potential participants, and standardized processes to ensure consistent, fast, and high-quality trial execution for sponsors.

Opportunities

The growing global focus on pandemic preparedness and antimicrobial resistance (AMR) drives significant R&D investment in infectious diseases, creating strong demand for expert site partners.
AMR Clinical's integrated network model directly addresses industry pain points of slow enrollment and site variability, positioning it to capture market share as sponsors seek to de-risk and accelerate trials.

Risk Factors

Revenue is concentrated in the infectious disease and diagnostics sectors, making it vulnerable to shifts in pharmaceutical R&D funding priorities.
Maintaining consistent quality and performance across a growing network of sites is an ongoing operational challenge, and any significant compliance or enrollment failure could damage the integrated brand's reputation.

Competitive Landscape

AMR Clinical competes with large, global contract research organizations (CROs) that have their own site networks, as well as other specialized site management organizations (SMOs) and independent clinical research sites. Its differentiation lies in its deep specialization in infectious diseases, its fully integrated and owned site model ensuring consistency, and its large, proprietary patient database aimed at enabling faster enrollment.